Patient Selection in Melanoma: Immunotherapy vs Targeted Therapy – OncLive
OncLive |
Patient Selection in Melanoma: Immunotherapy vs Targeted Therapy
OncLive Panelists: Robert H.I. Andtbacka, MD, CM, Huntsman Cancer Institute; Michael A. Davies, MD, PhD, MD Anderson Cancer Center; Antoni Ribas, MD, PhD, University of California Los Angeles; Georgina Long, MD, Melanoma Institute of Australia; Michael … |
